- New pancreatic cancer drug carries a $39,800 monthly list price: What to know Yahoo Finance
- FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
- FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer BBC
- New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many The New York Times
- U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease Scientific American
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь